![]() RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | ![]() Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1781 | Founding Date 1921 | Founding Date 1978 | Founding Date 2012 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Epalinges, CH HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ | |
Employees | Employees 254% decrease | Employees 47,4554% decrease | Employees 1,681 | Employees 16,315 | Employees 2,578 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹150.5b (FY, 2025) | Revenue (est.) ¥1.9b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A | Cost of goods ₹52b (FY, 2025) | Cost of goods ¥410.7m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A | Gross profit ₹112.7b (FY, 2025) | Gross profit ¥1.5b (FY, 2024) |
Net income | Net income N/A | Net income ¥108.1b (FY, 2025) | Net income N/A | Net income ₹14.3b (FY, 2025) | Net income (¥1.4b) (FY, 2024) |
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View companyShanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company